Public Health Initiatives by Takeda to Strengthen Health System
for Rare Diseases in India
Mumbai, May 17, 2023: Takeda Biopharmaceuticals India Private Limited (formerly known as Baxalta Bioscience India Private Limited), a global values-based, R&D-driven biopharmaceutical leader conducted dissemination of its public health initiatives in strengthening the health system for rare diseases (RD) in India. These initiatives aim to improve access to healthcare for rare disease patients who otherwise face significant outcomes like childhood disabilities and life-long morbidity, early mortality, and progressively poor Quality of Life. The meeting was witnessed by Takeda’s partners including APCO Worldwide, MAMTA Health Institute for Mother and Child, US-India
Visit http://educratsweb.com/3935-content.htm
Visit http://educratsweb.com/3935-content.htm
This post first appeared on NEWS, EDUCATIONAL NOTES, ENTERTAINMENT, PRACTICE SET, VIDEO ETC, please read the originial post: here